Download presentation
Presentation is loading. Please wait.
Published byElvin Booker Modified over 6 years ago
1
Global burden of HIV, viral hepatitis and TB in prisoners
Kate Dolan, Andrea Wirtz, Babak Moazen, Martial Ndeffo-mbah, Alison Galvani, Stuart Kinner, Ryan Courtney, Martin McKee, Joe Amon, Lisa Maher, Margaret Hellard, Chris Beyrer & Fredrick L Altice
2
Aims and methods Global number of inmates with HIV, HCV, HBV & TB
Pooled estimated prevalence by region and incidence (new cases) Model impact of incarceration and OAT on HIV incidence Comprehensive review 196 countries Studies with biological markers of HIV, HCV, HBV and TB Prisons, jails and Compulsory Drug Detention Centres HIV and related infections in prisoners
3
Results: Of 10 million inmates *
Infection Number of inmates infected % infected HIV 389,000 3.8 HCV 1,546,500 15.1 HBV 491,500 4.9 TB 286,000 2.8 * ~30 million enter and leave prison each year HIV and related infections in prisoners
4
HIV HCV HBV & TB prevalence by region
HIV and related infections in prisoners
5
HIV prevalence in prisoners n=74 countries
HIV and related infections in prisoners
6
HCV prevalence in prisoners n=46 countries
HIV and related infections in prisoners
7
HBV prevalence in prisoners n=43 countries
HIV and related infections in prisoners
8
TB prevalence in prison n=25 countries
HIV and related infections in prisoners
9
HIV, HCV & HBV incidence in prison n=5 countries
10
Model: Incarceration and OAT on HIV transmission
Contribution of incarceration ↓ PWID in prison by 25% will ↓ HIV rate by 7-15% Contribution of OAT ↑ OAT in prison by 20% will ↓ HIV rate by 28% Modelled various scenarios to reduce HIV incidence HIV and related infections in prisoners
11
Compulsory Drug Detention Centres
Suspected drug users held in 27 countries East/South East Asia, 600,000 ppl in 1,000 centres Latin America & sub-Saharan Africa unknown number Extra-judicial & forced labour as “drug treatment” Inhumane conditions are common [skin on the cable] Evidence-based prevention & treatment are rare HIV and related infections in prisoners
12
Limited data on TB and incidence for all infections
Conclusions Limited data on TB and incidence for all infections Millions of prisoners are infected High HIV in African Regions reflects community epidemic High HCV in six regions West Central Africa, MENA, Asian/Pacific, East & West Europe & Nth America High HBV in West Central Africa & East Europe Over representation of PWID going to prison Levels much higher inside prison than outside HIV and related infections in prisoners
13
Introduce alternatives to imprisonment
Recommendations Expand harm reduction, drug treatment, ART, PrEP HBV vaccinations, HCV treatment in the community Introduce alternatives to imprisonment Improve prison health care to community levels Test and treat and prevent infections in prisoners Lobby Govts close Compulsory Drug Detention Centres and provide effective treatment Collect more data esp Caribbean HIV and related infections in prisoners
14
Acknowledgements UK: Lancet
USA: National Institute on Drug Abuse, National Institute of Health, MACAIDS, Gates Foundation, Open Society Foundations Australia: National Drug & Alcohol Research Centre, Cancer Institute NSW, National Health & Medical Research Council Germany: Deutscher Akademischer Austauschdienst United Nations Population Fund, UNODC, EMCDDA HIV and related infections in prisoners
15
Affiliations Australia: Program of International Research and Training (PIRT) University of New South Wales, Griffith Criminology Institute, Burnet Institute USA: Johns Hopkins School of Public Health, Yale University, Human Rights Watch UK: London School of Hygiene & Tropical Medicine Iran: Tehran University of Medical Sciences HIV and related infections in prisoners
16
infections in prisoners
HIV and related infections in prisoners Thank you
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.